Integrating Solution Focused Interventions in Integrated Care

NCT05838222 | Completed

• 1 other identifier: 00006727
• Study Type: interventional
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

Integrated behavioral healthcare (IBH) emerged to address the high prevalence of psychosocial issues endemic to primary care settings coupled with primary care provider's discomfort in addressing psychosocial issues. IBH addresses the lack of psychosocial care in primary care settings by expanding the traditional healthcare team through the inclusion of a behavioral health provider (clinical social worker, licensed psychologist, etc.). The behavioral health provider utilizes evidenced based interventions to support the healthcare team with addressing a wide range of healthcare concerns. Solution Focused Brief Therapy (SFBT) provides a promising treatment approach within IBH settings due to the high productivity standards within primary care and the efficient, solution based style foundational to SFBT. In addition, SFBT is strengths based and emphasizes patient centered approaches which primary care aspires to achieve. Despite the natural fit, there is a paucity of research regarding SFBT within integrated care settings in general, and for specific disease states. The purpose of this study is to assess the efficacy of SFBT within an IBH setting in the treatment of depression while assessing for commensurate improvement with traditional healthcare markers such as A1C, blood pressure, pulse, and weight. In addition, scaling questions will be utilized to assess for increase in core SFBT constructs to include self-awareness of strengths, future hope, and increased ability to problem solve. A pre-posttest experimental design will assess the differences between those receiving SFBT and treatment as usual across symptoms of depression, SFBT core attributes, and health outcomes.

Conditions

Depression; Diabetes Mellitus; Hypertension; Anxiety Disorders

Keywords

Integrated care; Solution focused; Primary Care; co occurring disorders

Outcome Measures

Primary Outcomes (5)

• Solution Focused Scaling Questions

  The authors utilized a solution-focused treatment manual to extract the essential ingredients of solution-focused treatment and create a scale measuring the degree to which participants 1) have experienced hope, 2) experienced connection to important people, 3) identified their strengths, 4) have hope for a "good" future, and 5) believe they could solve problems in their lives over the past two weeks. Each of these questions occurred on a 1-10 scale where 1 was "not at all" and 10 was "completely." This screening tool was provided to participants in paper format where participants self-administered the survey.

  4 months

• Depression outcomes

  Assess efficacy of SFBT for depression. The investigator will examine differences between the treatment and control group for depression scores utilizing the patient health questionnaire (PHQ-9.)

  4 months

• Diabetes Outcomes

  Assess efficacy of SFBT for diabetes. The investigator will examine differences between the treatment and control group for depression scores utilizing HbA1c.

  4 months

• Acceptability measure

  Evaluate acceptability for SFBT. The Acceptability of Intervention measure (AIM) will be used to assess the acceptability of the intervention for the treatment group. The AIM measures acceptability by asking participants whether the intervention 1) met their approval, 2) is appealing to them, 3) whether they like the intervention, and 4) whether they would welcome the intervention. A 5-point Likert scale is utilized to assess each of these domains. The scale will be self-administered by participants.

  4 months

• Feasibility measure

  Evaluate feasibility for SFBT. The Feasibility of Intervention measure (FIM) will be used to assess the feasibility of the intervention for the treatment group. The FIM assesses whether the participant believes that the intervention seems 1) implementable, 2) possible, 3) doable, and 4) easy to use. A 5-point Likert scale is utilized to assess each of these domains. The scale will be self-administered by participants.

  4 months

Secondary Outcomes (1)

• Hypertension

  4 months

Study Arms (2)

Intervention Group

EXPERIMENTAL

The intervention group will receive 3 sessions of SFBT from a licensed therapist in addition to treatment as usual

Behavioral: Solution Focused Intervention; Other: Treatment as Usual

Control

ACTIVE COMPARATOR

This group will be the treatment as usual group who will receive primary care treatment without the SFBT intervention

Other: Treatment as Usual

Interventions

Solution Focused Intervention BEHAVIORAL

A short term, goal focused, therapeutic approach which helps patients address problems contributing to health and mental health challenges

Intervention Group

Treatment as Usual OTHER

The patient receives standardized care from primary care team without the SFBT intervention

Control; Intervention Group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Over 18 years old
• PHQ9\>10

You may not qualify if:

• No significant co occurring mental health disorders

Sponsors & Collaborators

• University of Georgia: lead

Study Sites (1)

University of Georgia

Athens, Georgia, 30602, United States

Location

Related Publications (2)

• Cooper ZW, Johnson L. Strategies for Fidelity Monitoring a Solution-Focused Brief Intervention in a Randomized Clinical Trial. J Clin Psychol Med Settings. 2025 Sep;32(3):421-430. doi: 10.1007/s10880-025-10063-7. Epub 2025 Jan 28.

  PMID: 39873935 DERIVED

• Cooper ZW, Mowbray O, Ali MK, Johnson LCM. Addressing depression and comorbid health conditions through solution-focused brief therapy in an integrated care setting: a randomized clinical trial. BMC Prim Care. 2024 Aug 23;25(1):313. doi: 10.1186/s12875-024-02561-8.

  PMID: 39179982 DERIVED

MeSH Terms

Conditions

Depression; Diabetes Mellitus; Hypertension; Anxiety Disorders

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Behavioral Symptoms; Behavior; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Vascular Diseases; Cardiovascular Diseases; Mental Disorders

Study Officials

• Orion Mowbray, PhD

  University of Georgia

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Dean of Research

Model Details: Pretest-posttest experimental design with a treatment as usual group and an intervention group

Study Record Dates

• First Submitted: April 6, 2023
• First Posted: May 1, 2023
• Study Start: May 8, 2023
• Primary Completion: August 11, 2023
• Study Completion: October 2, 2023
• Last Updated: October 18, 2023

Record last verified: 2023-10

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)